VRTX SEC filings last scanned 13 May 2026, 22:42 UTC
CEO Timeline
Reshma KewalramaniCurrent
Apr 2020 — Present(6y 1mo)
Reshma Kewalramani, M.D. was appointed President and Chief Executive Officer of Vertex Pharmaceuticals, succeeding Dr. Jeffrey M. Leiden effective April 1, 2020.
3 source filings — click to expand
Jeffrey M. Leiden
Feb 2012 — Mar 2020(8y 1mo)
Dr. Jeffrey M. Leiden was appointed President and Chief Executive Officer of Vertex Pharmaceuticals, effective February 1, 2012, succeeding Matthew W. Emmens.
transition to Executive Chairman role
5 source filings — click to expand
Matthew Emmens
May 2009 — Feb 2012(2y 9mo)
Matthew Emmens was appointed Chief Executive Officer and Chairman of Vertex Pharmaceuticals, effective May 23, 2009, succeeding Joshua S. Boger.
planned transition to Executive Chairman, with planned retirement on May 22, 2012